INTRODUCTION
The association of Neotyphodium coenophialum with tall fescue (Lolium arundinaceum) results in production of numerous ergot alkaloids (Lyons et al., 1986) .
Ergot alkaloids have been implicated in causing vasoconstriction, which is a source of clinical symptoms of the fescue toxicosis syndrome . Prior research has mainly focused on constriction of peripheral vasculature like the caudal artery (Aiken et al., 2007) , saphenous vein (Klotz et al., 2006) , and the dorsal pedal vein (Solomons et al., 1989) . There is a paucity of data addressing the effects of ergot alkaloids on vasculature supporting core body tissues. Rhodes et al. (1991) is the only study that has addressed this. Using labeled microspheres, they reported a reduction in blood flow to the duodenum, colon, and kidney of cattle consuming endophyte-infected tall fescue at high ambient temperatures. Westendorf et al. (1992) , Moyer et al. (1993) , and DeLorme et al. (2007) all assert that the rumen is the primary site of alkaloid liberation, degradation, and possibly absorption. Bovine ruminal tissue has been shown to have a capacity to absorb ergot alkaloids (Ayers et al., 2009 ). Using sheep, Westendorf et al. (1993) demonstrated that only 50 to 60% of ingested alkaloids are recovered in abomasal contents. The fraction of alkaloids disappearing in the reticulorumen likely represents both microbial degradation and absorption. It is hypothesized that absorption of ergot alkaloids combined with the tendency of ergopeptine alkaloids to bioaccumulate in vascular tissue (Klotz et al., 2009 ) could result in vasoconstriction and a concomitant reduction in blood flow. Klotz et al. (2011) recently developed a ruminal artery and vein bioassay designed to evaluate the response different toxicants elicit. Therefore, the objective of this study was to determine if ergoline and ergopeptine alkaloids ( Figure  1 ) would elicit a vasoactive response in bovine ruminal artery and vein preparations in vitro.
MATERIALS AND METHODS
Methods used with live animals in this study were approved by the University of Kentucky Institutional Animal Care and Use Committee.
Animals and Tissues
Predominantly Angus-bred heifers (n = 10; BW = 498 ± 9 kg) were utilized in this study. Heifers were fed a basal diet consisting of cotton seed hulls, soybean hulls, corn, and soybean meal (41.9, 31.4, 21.45, and 5.25% of diet on an as-fed basis, respectively). The nutrient composition of the diet was 9.9% CP and 58.0% NDF on a DM basis. Heifers were fed this diet for a minimum of 232 d.
Sections of right ruminal artery and vein were collected from the ventral coronary groove of the rumen shortly after each animal was stunned by captive bolt, exsanguinated, and eviscerated at the University of Kentucky abattoir. Tissues were immersed in a modified Krebs-Henseleit oxygenated buffer (95% O 2 + 5% CO 2 ; pH = 7.4; mM composition = d-glucose, 11.1; MgSO 4 , 1.2; KH 2 PO 4 , 1.2; KCl, 4.7; NaCl, 118.1; CaCl 2 , 3.4; and NaHCO 3 , 24.9; Sigma Chemical Co., St. Louis, MO) and placed on ice for transport to the laboratory.
Artery and vein were separated, cleaned of excessive fat and connective tissue, sliced into 2-to 3-mm cross sections, and examined under a dissecting microscope (Stemi 2000-C, Carl Zeiss Inc., Oberkochen, Germany) at 12.5× magnification to ensure structural integrity of the vessel. Dimensions of the blood vessels were recorded (Axiovision, version 20, Carl Zeiss Inc.) to ensure the segment size was consistent. Vessel segments were then mounted on luminal supports in a tissue bath (DMT610M Multichamber myograph, Danish Myo Technologies, Atlanta, GA) containing 5 mL of continuously gassed (95% O 2 + 5% CO 2 ) modified KrebsHenseleit buffer at 37°C. The buffer used for transport was further modified for tissue incubation by adding desipramine (3 × 10 −5 M; D3900 Sigma Chemical Co.) and propranolol (1 × 10 −6 M; P0844, Sigma Chemical Co.) to inactivate neuronal reuptake of catecholamines C) Generalized structure of ergopeptine alkaloids indicating the variable R 1 and R 2 sites. Common R 1 groups are methyl (ergotamine, ergovaline, and α-ergosine) and isopropyl (ergocristine, ergocornine, and α-ergocryptine). Common R 2 groups are isopropyl (ergovaline and ergocornine), isobutyl (α-ergosine and α-ergocryptine), and methyl benzyl (ergotamine and ergocristine).
and to block β-adrenergic receptors, respectively. Tissue samples were equilibrated to a resting tension of 1.0 g for ruminal artery and 0.5 g for ruminal vein for 90 min with buffer replacement at 15-min intervals, as validated by Klotz et al. (2011) . Vessels were then exposed to KCl (120 mM) to ensure tissue viability and to provide a reference for normalization of contractile responses.
Concentration Responses of Ergot Alkaloids
Stock standards of ergovaline tartrate (≥93% purity, supplied by F. T. Smith, Auburn University, Auburn, AL), ergotamine d-tartrate (≥97% purity, #45510, Fluka, Sigma Chemical Co.), α-ergocryptine (99% purity, E5625, Sigma Chemical Co.), and ergocristine (05-9034-17, Research Plus Inc., Barnegat, NJ) were prepared in 100% methanol. d-Lysergic acid hydrate (95% purity, Acros Organics, Geel, Belgium) was prepared in 80% (vol/vol) methanol that contained 1.2 × 10 −4 M acetic acid. Ergonovine maleate (100% purity, E6500, Sigma Chemical Co.) was prepared in H 2 O. Ergocornine (>95% purity, E131, Sigma Chemical Co.) was prepared in dimethyl sulfoxide. Standards were prepared in a concentration of 2 × 10 −2 M and added in 25-µL aliquots to achieve a concentration of 1 × 10 −4 M in the tissue bath. This kept concentration of vehicle below 0.5% in the incubation buffer. Serial dilutions of 2 × 10 −2 M stock alkaloid standards were prepared to achieve the desired treatment concentrations ranging from 1 × 10 −11 to 1 × 10 −4 M in the myograph baths, except for ergotamine, which was prepared at 2 × 10 −3
M with a maximum concentration in the incubation buffer of 1 × 10 −5 M.
Data Collection and Analysis
Isometric contractile responses to KCl, lysergic acid, ergonovine, ergocristine, ergocryptine, ergocornine, ergotamine, or ergovaline were digitized and recorded as grams of tension using a Powerlab/8sp and Chart software (version 7.1, ADInstruments, Colorado Springs, CO). The maximum tension observed for the 9-min incubation period after the addition of a treatment was recorded and corrected for baseline tension measured just before the addition of the 120 mM KCl reference addition. Values were normalized as a percentage of the contractile response induced by the KCl reference addition to compensate for differing responses due to tissue size and animal variation. Contractile response data are presented as percentage means ± SEM of the maximum contractile effect induced by 120 mM KCl. Alkaloid potency was calculated from the concentration response data using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA) and is presented as the molar concentration of the alkaloids producing 50% of the maximum response (EC 50 ). This analysis utilized 
Statistical Analysis
Contractile response data of ruminal artery and veins exposed to ergot alkaloids were analyzed as a completely randomized design using the mixed model procedure (SAS Inst. Inc., Cary, NC). Terms of the model included alkaloid, concentration, vessel, and all interactions. For the comparison of E max and EC 50 data, the interactions of alkaloid × vessel and effect of vessel were not significant (P = 0.18 and 0.23, respectively); therefore, these terms were removed from the model, and the E max and EC 50 data were analyzed separately for artery and vein. After ANOVA, pair-wise comparisons of least squares means (±SEM) were conducted using LSD if the probability of a greater F-statistic was significant for the tested effect.
RESULTS AND DISCUSSION
Exposure of ruminal artery and vein segments to ergot alkaloids resulted in an interaction between alkaloid, concentration, and vessel type (artery or vein) for the contractile response data (P < 0.0001). Concentration response curves for the ruminal artery are shown in Figure 2 . Contractile responses were first observed for ergovaline (P = 0.016) and ergotamine (P = 0.019) at 10 −6 M concentration. Ergonovine (P = 0.04), ergocornine (P = 0.002), and ergocryptine (P = 0.014) did not cause an arterial contraction until exposure to the 10 −5 M dose, and ergocristine did not elicit a response until the 10 −4 M addition (P = 0.042). Studies measuring the effect of ergot alkaloids on bovine arteries have been limited; however, in vitro contractile responses have been reported for lysergamide in bovine metatarsal artery (Oliver et al., 1993) and ergovaline in bovine uterine artery (Dyer, 1993) . Both studies demonstrated that the ergot alkaloids tested caused significant vasoconstriction. Consumption of ergot alkaloids from endophyte-infected tall fescue was also shown to induce in vivo vasoconstriction of the caudal artery in heifers within either 4 h (Aiken et al., 2007) or 27 h ) of initial consumption.
The EC 50 for the ruminal artery (Table 1) were similar for all alkaloids except ergotamine, which was greater (P = 0.0107), indicating that ergotamine is least potent at stimulating ruminal artery contraction. However, ergotamine exposure may still be as significant a risk to foregut blood flow as the other ergot alkaloids tested here if bioaccumulation (Klotz et al., 2009) or metabolism affect target tissue concentrations in vivo. The E max (Table 1) was greatest for ergovaline and least for ergocristine. Previous studies have led to the theory that ergopeptines (i.e., ergovaline) have a greater vasoconstrictive activity than the ergoline alkaloid lysergic acid (Klotz et al., 2006 (Klotz et al., , 2007 . However, more recent studies have reported that the ergoline alkaloid, ergonovine, has an E max equal to or greater than some ergopeptine alkaloids (Klotz et al., 2010) . The ruminal artery data from the present study indicate a similar trend where ergonovine possessed an E max similar to ergotamine, ergocornine, and ergocryptine, and a greater response than ergocristine (Table 1) . n/a n/a n/a Ergonovine 1.1 × 10 −5b ± 4.4 × 10 −6 (10) 20.8 cd ± 2.7 n/a n/a Ergocornine 1.2 × 10 −5b ± 4.4 × 10 −6 (10) 24.8 bc ± 2.7 n/a n/a Ergocryptine 8.6 × 10 −6b ± 4.4 × 10 −6 (10) 22.0 bcd ± 2.7 1.7 × 10 −5a ± 3.9 × 10 −5 (7) Means within a column containing different superscripts differ (P < 0.05). 1 EC 50 = measure of the potency of an alkaloid, expressed as the molar concentration required to produce 50% of the maximum contractile response. E max = maximal contractile response observed, expressed as a percentage of the 120 mM KCl reference addition response.
2 Some data did not fit a sigmoidal curve preventing the calculation of EC 50 values for some data. This resulted in variable numbers of experimental replicates, which are denoted in parenthetical values following each SEM for EC 50 values.
3 For E max values, n = 10 except ergotamine (n = 9) and lysergic acid (n = 9). 4 n/a = no contractile response was measured for these vessels in response to these ergot alkaloids (P > 0.05). 5 Ergotamine was only soluble at 2 × 10 −3 M resulting in a maximum concentration in the incubation buffer of 1 × 10 −5 M.
Concentration response curves for ruminal vein are shown in Figure 3 . Exposure of the ruminal vein to ergovaline, ergotamine, ergocryptine, and ergocristine induced contractile responses, whereas ergonovine (P = 0.094) only produced a slight response at the 10 −4 concentration. Ergocornine (P = 0.156) and lysergic acid (P = 0.5692) did not produce a contractile response. The smallest alkaloid concentration where a response was observed was 10 −6 M for ergovaline (P = 0.009) and ergotamine (P = 0.017), 10 −5 M for ergocryptine (P = 0.029), and 10 −4 M for ergocristine (P = 0.005). The EC 50 for alkaloids tested in the ruminal vein (Table  1) were similar (P = 0.205) for alkaloids eliciting a contractile response. Ergovaline had the greatest E max for the ruminal vein (P < 0.0001; Table 1 ) but did not differ from ergotamine (P = 0.205). Ergotamine also did not differ from ergocryptine (P = 0.133) or ergocristine (P = 0.249). Similar alkaloid profiling studies using the bovine lateral saphenous vein model indicated that ergocryptine and ergocristine had similar E max values (Klotz et al., 2010) , and venous data presented in the current study follows the same pattern of the previous report with similar contractile responses to ergocryptine and ergocristine. Responses of the ruminal vein to ergotamine and ergovaline indicates (similar E max values) another similarity of the ruminal vein to the peripheral vasculature model (Klotz et al., 2007) . The lack of a response from lysergic acid, ergonovine, and ergocornine has not been previously reported and differs from what was reported for peripheral vasculature (Klotz et al., 2006 (Klotz et al., , 2010 . Ergonovine has been shown to have a greater E max than ergocryptine and ergocristine in peripheral vasculature (Klotz et al., 2010) . This may be a result of the difference in functions of tissue that peripheral and core vasculature serve.
Ergovaline induced a greater contractile response in the ruminal artery than in the ruminal vein (P < 0.0001) but ergocryptine (P = 0.218), ergocristine (P = 0.425), and ergotamine (P = 0.162) produced similar responses in both vessel types. In contrast, a previous study comparing the response of bovine lateral saphenous vein and dorsal metatarsal artery with lysergamide showed that the vein was more sensitive to the ergot alkaloid than the artery (Oliver et al., 1993) . These opposing results could be due to differences in the alkaloids tested or a difference in peripheral versus core vasculature.
Earlier reports have led to the development of a hypothesis that ergopeptines that are similar at the R 1 position ( Figure 1C ) but differ at the R 2 position will result in similar contractile responses in the multimyograph bioassay (Klotz et al., 2010) . This hypothesis was supported by findings that ergopeptines that share an R 1 methyl group (ergovaline and ergotamine) resulted in similar contractile responses in the lateral saphenous vein (Klotz et al., 2007) . The hypothesis was further substantiated when ergopeptines with an isopropyl R 1 group resulted in similar contractile responses in the lateral saphenous vein (Klotz et al., 2010) . Results in Figure 3 . Contractile responses of right ruminal vein preparations to A) increasing concentrations of ergocornine (ERO), ergocryptine (ERP), and ergocristine (ERS); B) ergotamine (ERT) and ergovaline (ERV); and C) ergonovine (ERN) and lysergic acid (LSA; n = 10 each except ERT and LSA, n = 9 each). Effects of alkaloid, concentration, and alkaloid × concentration were significant (P < 0.05); however, ERO and LSA failed to induce a contractile response. The ERN induced only a slight response (P = 0.094). Regression lines represent the fitting of data to a sigmoidal concentration response curve with the following 3-parameter equation: y = bottom + top -bottom / 1 + 10
where top and bottom are the plateaus in the units of percent of 120 mM KCl contractile response and EC 50 is the molar concentration of the alkaloids producing 50% of the maximum response. Missing regression lines indicate data could not be fit to the concentration response model. the current study for ergot alkaloids that have a methyl R 1 group (ergovaline and ergotamine) produced similar contractile responses in the ruminal vein, but not in the ruminal artery. Similarities were also seen between ergocristine and ergocryptine (isopropyl R 1 ) in the ruminal vein, but the contractile response was different from ergocornine, which also has an isopropyl R 1 . The difference between the methyl and isopropyl R 1 also was not observed in the ruminal vein indicated by similar contractile responses for ergocristine, ergocryptine, and ergotamine. These apparent differences in responses between ruminal and peripheral vessels could be the result of different receptor populations present on the various blood vessels combined with the fairly promiscuous binding of ergot alkaloids with the different biogenic amine receptors (Weber, 1980 ).
In the current study, lysergic acid failed to induce a significant contractile response in the ruminal artery or vein. Lysergic acid has been previously reported to cause a contractile response in lateral saphenous vein but only at 10 −4 M, which represents a supraphysiological concentration (Klotz et al., 2006 ) that a grazing animal would likely never encounter. The previous report from Klotz et al. (2006) combined with data presented in the current study demonstrating a lack of response in ruminal vasculature indicate that lysergic acid does not exert a direct vasoconstrictive effect on bovine tissues.
The data presented in this study show that ergot alkaloids have the potential to induce vasoconstriction of the bovine right ruminal artery and vein. Constriction of foregut vasculature could significantly reduce blood flow to or from the rumen of cattle consuming endophyte-infected tall fescue. A reduction in blood flow could result in decreased absorption rates of vital nutrients and fermentative end products. Diminished nutrient absorption could contribute to the reduced growth rates and poor performance observed in cattle grazing endophyte-infected tall fescue. Knowing this, it is critical that future research be directed at determining the primary site(s) and mechanisms of ergot alkaloid absorption.
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